国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Candida glabrata DASH complex subunit DUO1 (DUO1) CSB-YP749858CZI
CSB-EP749858CZI
CSB-BP749858CZI
CSB-MP749858CZI
CSB-EP749858CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata ATPase expression protein 1, mitochondrial (AEP1) CSB-YP749859CZI
CSB-EP749859CZI
CSB-BP749859CZI
CSB-MP749859CZI
CSB-EP749859CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata ATP-dependent RNA helicase MSS116, mitochondrial (MSS116), partial CSB-YP749860CZI
CSB-EP749860CZI
CSB-BP749860CZI
CSB-MP749860CZI
CSB-EP749860CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Heterogeneous nuclear rnp K-like protein 2 (HEK2) CSB-YP749861CZI
CSB-EP749861CZI
CSB-BP749861CZI
CSB-MP749861CZI
CSB-EP749861CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Protein EFR3 (EFR3), partial CSB-YP749862CZI
CSB-EP749862CZI
CSB-BP749862CZI
CSB-MP749862CZI
CSB-EP749862CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata rRNA-processing protein FYV7 (FYV7) CSB-YP749863CZI
CSB-EP749863CZI
CSB-BP749863CZI
CSB-MP749863CZI
CSB-EP749863CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Pyruvate kinase 2 (PYK2), partial CSB-YP749864CZI
CSB-EP749864CZI
CSB-BP749864CZI
CSB-MP749864CZI
CSB-EP749864CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Nitrogen permease regulator 3 (NPR3), partial CSB-YP749865CZI
CSB-EP749865CZI
CSB-BP749865CZI
CSB-MP749865CZI
CSB-EP749865CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata COP9 signalosome complex subunit 10 (RRI2), partial CSB-YP749866CZI
CSB-EP749866CZI
CSB-BP749866CZI
CSB-MP749866CZI
CSB-EP749866CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata tRNA (guanine-N (7)-)-methyltransferase subunit TRM82 (TRM82) CSB-YP749867CZI
CSB-EP749867CZI
CSB-BP749867CZI
CSB-MP749867CZI
CSB-EP749867CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata DNA replication complex GINS protein PSF1 (PSF1) CSB-YP749868CZI
CSB-EP749868CZI
CSB-BP749868CZI
CSB-MP749868CZI
CSB-EP749868CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata DNA replication complex GINS protein PSF3 (PSF3) CSB-YP749869CZI
CSB-EP749869CZI
CSB-BP749869CZI
CSB-MP749869CZI
CSB-EP749869CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Altered inheritance of mitochondria protein 3-1 (AIM3-1), partial CSB-YP749870CZI
CSB-EP749870CZI
CSB-BP749870CZI
CSB-MP749870CZI
CSB-EP749870CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata GTPase-activating protein GYP7 (GYP7), partial CSB-YP749871CZI
CSB-EP749871CZI
CSB-BP749871CZI
CSB-MP749871CZI
CSB-EP749871CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Histone H2A.1 (HTA1) CSB-YP749872CZI
CSB-EP749872CZI
CSB-BP749872CZI
CSB-MP749872CZI
CSB-EP749872CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (SDH2), partial CSB-YP749873CZI
CSB-EP749873CZI
CSB-BP749873CZI
CSB-MP749873CZI
CSB-EP749873CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Protein DSE3 (DSE3) CSB-YP749874CZI
CSB-EP749874CZI
CSB-BP749874CZI
CSB-MP749874CZI
CSB-EP749874CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Zinc-regulated protein 8 (ZRG8), partial CSB-YP749875CZI
CSB-EP749875CZI
CSB-BP749875CZI
CSB-MP749875CZI
CSB-EP749875CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Serine/threonine-protein kinase MEC1 (MEC1), partial CSB-YP749876CZI
CSB-EP749876CZI
CSB-BP749876CZI
CSB-MP749876CZI
CSB-EP749876CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Palmitoyltransferase SWF1 (SWF1), partial CSB-YP749877CZI1
CSB-EP749877CZI1
CSB-BP749877CZI1
CSB-MP749877CZI1
CSB-EP749877CZI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>